Log In
Wednesday 23rd May 2018

New approach to pathology and genetics brought to Manchester

17th August 2010

Central Manchester University Hospitals NHS Foundation Trust and GSTS Pathology launch new collaboration.

Central Manchester University Hospitals NHS Foundation Trust and GSTS Pathology LLP have launched a new collaboration to develop pathology and genetic services in the North West of England.  The two organisations have signed a Memorandum of Understanding to this effect.

The new venture will help the Trust continue to modernise the pathology services it provides, increasing quality and efficiency, to provide a better service for doctors and to ultimately improve patient outcomes.  It will also support the wider region in delivering the recommendations of the Lord Carter Report.

The collaboration will comprise joint business development and tendering for opportunities, which will be delivered jointly by the two organisations.  It will also enable the nationally renowned genetic testing service based at Saint Mary's hospital to identify business and strategic development opportunities.

"We are excited by the possibilities this new partnership with GSTS Pathology offers, and the benefits it will bring to patients and staff," said Mike Deegan, Chief Executive of the Trust.  "It reinforces our plans to consolidate and develop our diagnostic services to meet the needs of a changing NHS, by focusing on delivering the highest levels of quality, patient safety and efficiency."

The Trust is a UK Centre of Excellence for Laboratory and Genetic Medicine, and home to a new £50m state-of-the-art Clinical Sciences Building with adult and paediatric pathology facilities. The five hospitals within the Trust have more than one million patient contacts each year, and around seven million diagnostic tests are processed each year.

GSTS Pathology (a 50:50 Joint Venture between Guy’s & St Thomas’ NHS Foundation Trust and Serco Group Plc) is one of the largest pathology organisations in the UK.  Over 650 medical, academic, technical and ancillary staff process over 8 million pathology tests per year.  For the Trust, the collaboration brings access to the service transformation skills and business development expertise of GSTS Pathology.

Added Dr Kevin Cox, Managing Director of GSTS Pathology: “GSTS is delighted to be in partnership with such a strong and forward looking organisation.  By pooling our resources and seeking innovative solutions I am confident that together we can drive improvements in pathology services in the North West, and beyond, for the benefit of users and patients alike.”

The Trust will also continue to work closely with other laboratories across Greater Manchester, to help deliver high quality pathology services for patients across the region.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: New approach to pathology and genetics brought to Manchester
Author: Rachel Sumbler
Article Id: 15813
Date Added: 17th Aug 2010


GSTS Pathology

Recent Related Articles

Newcastle Hospitals appoints new chief executive


Add to scrapbook
Show Comments
Add comment
Find all related articles


M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018